<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03055260</url>
  </required_header>
  <id_info>
    <org_study_id>1612M02121</org_study_id>
    <nct_id>NCT03055260</nct_id>
  </id_info>
  <brief_title>Low Intensity Blood Flow Restriction Training Study</brief_title>
  <official_title>Effect of Low Intensity Blood Flow Restriction Training on Lower Extremity Strength and Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fairview Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The particpant will complete baseline testing by measuring subjects' quadriceps muscle
      thickness (cm) via ultrasound technology, as well as have them complete a one repetition
      maximum (1RM) test on the leg press machine and an isometric knee extension using a
      dynamometer - strength measures will be calculated for both right and left legs. After
      baseline testing, subjects will complete 6 weeks of the testing protocol that will consist of
      leg press exercises at 30% of their 1RM. Subjects will be randomized to either wear a cuff
      that partially restricts blood flow to the limb (Study Group), or to wear a cuff that does
      not restrict blood flow (Control Group). Exercises will be completed 2x/week and will take
      approximately 10 total minutes (5 for warm up, 5 for testing protocol) per session. After 6
      weeks, muscle thickness, leg press 1RM, and quadriceps extension strength will be re-tested
      and compared to the initial measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Session 1 - baseline testing

        -  5-minute warm-up; 1RM calculation for both right and left legs using a supine leg press
           machine; isometric quadriceps strength measurement using a dynamometer; muscle thickness
           measurements of both right and left quadriceps muscle using ultrasound technology.

        -  After day 1 testing; randomly allocate subjects to either control group or experimental
           group

      Sessions 2-13 - 6 weeks of exercise protocol, 2x/per week

      Both the experimental and control groups will complete the same protocol for the entirety of
      the study:

        -  5- minute warm up

        -  Using a single-leg press exercise machine: Subjects complete the testing protocol with
           either partial blood flow restriction (cuff inflated to 100-250 mmhg depending on size
           of person) or no blood flow restriction (placebo inflation) on right limb.

             -  Protocol: 30 repetitions - 15 repetitions - 15 repetitions - 15 repetitions with
                each set separated by ~30-90 seconds.

             -  Right and left legs will be alternating, but only one leg will have the occlusion
                cuff

      Session 14 - Re-test

      - Re-check 1RM, isometric quad strength, as well as muscle thickness of quadriceps with
      ultrasound
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 23, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>One Repetition Maximum</measure>
    <time_frame>6 weeks</time_frame>
    <description>One repetition maximum on the single leg press. Isometric quadriceps extension strength.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quadriceps Muscle Thickness</measure>
    <time_frame>6 weeks</time_frame>
    <description>Difference between groups in the measurement of the muscle thickness of the quadriceps muscle via ultrasound.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Muscle Mass</condition>
  <arm_group>
    <arm_group_label>Blood flow restriction cuff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood Flow restriction Cuff-Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood flow restriction cuff</intervention_name>
    <description>The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
    <arm_group_label>Blood flow restriction cuff</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood Flow restriction Cuff-Placebo</intervention_name>
    <description>The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
    <arm_group_label>Blood Flow restriction Cuff-Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-49

        Exclusion Criteria:

          -  Pregnant

          -  Hypertensive

          -  Recent back or lower extremity injury

          -  History of blood clotting

          -  Varicose veins

          -  Adults lacking the capacity to consent for themselves
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon Schoenecker, DPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fairview Health Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fairview Health Services</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Loenneke JP, Wilson JM, Mar√≠n PJ, Zourdos MC, Bemben MG. Low intensity blood flow restriction training: a meta-analysis. Eur J Appl Physiol. 2012 May;112(5):1849-59. doi: 10.1007/s00421-011-2167-x. Epub 2011 Sep 16.</citation>
    <PMID>21922259</PMID>
  </reference>
  <reference>
    <citation>Slysz J, Stultz J, Burr JF. The efficacy of blood flow restricted exercise: A systematic review &amp; meta-analysis. J Sci Med Sport. 2016 Aug;19(8):669-75. doi: 10.1016/j.jsams.2015.09.005. Epub 2015 Sep 28. Review.</citation>
    <PMID>26463594</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 8, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2017</study_first_posted>
  <results_first_submitted>February 13, 2020</results_first_submitted>
  <results_first_submitted_qc>February 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 28, 2020</results_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Research coordinator/statistician will have access to blinded, individual data for the purpose of record keeping and analysis.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03055260/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Blood Flow Restriction Cuff</title>
          <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.
Blood flow restriction cuff: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
        <group group_id="P2">
          <title>Blood Flow Restriction Cuff-Placebo</title>
          <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.
Blood Flow restriction Cuff-Placebo: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>No participants completed the placebo arm.</population>
      <group_list>
        <group group_id="B1">
          <title>Blood Flow Restriction Cuff</title>
          <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.
Blood flow restriction cuff: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
        <group group_id="B2">
          <title>Blood Flow Restriction Cuff-Placebo</title>
          <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.
Blood Flow restriction Cuff-Placebo: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.1" spread="6.2"/>
                    <measurement group_id="B3" value="28.1" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>One Repetition Maximum</title>
          <population>8 participants were enrolled. 1 participants dropped-out prior to collection of this data measure.</population>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="267.1" spread="63.2"/>
                    <measurement group_id="B3" value="267.1" spread="63.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Quadriceps Muscle Thickness</title>
          <population>8 participants were enrolled. 1 participants dropped-out prior to collection of this data measure.</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.4" spread="10.2"/>
                    <measurement group_id="B3" value="42.4" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>One Repetition Maximum</title>
        <description>One repetition maximum on the single leg press. Isometric quadriceps extension strength.</description>
        <time_frame>6 weeks</time_frame>
        <population>No participants completed the placebo arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Blood Flow Restriction Cuff</title>
            <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.
Blood flow restriction cuff: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
          </group>
          <group group_id="O2">
            <title>Blood Flow Restriction Cuff-Placebo</title>
            <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.
Blood Flow restriction Cuff-Placebo: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
          </group>
        </group_list>
        <measure>
          <title>One Repetition Maximum</title>
          <description>One repetition maximum on the single leg press. Isometric quadriceps extension strength.</description>
          <population>No participants completed the placebo arm.</population>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="302.9" spread="67.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quadriceps Muscle Thickness</title>
        <description>Difference between groups in the measurement of the muscle thickness of the quadriceps muscle via ultrasound.</description>
        <time_frame>6 weeks</time_frame>
        <population>No participants completed the placebo arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Blood Flow Restriction Cuff</title>
            <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.
Blood flow restriction cuff: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
          </group>
          <group group_id="O2">
            <title>Blood Flow Restriction Cuff-Placebo</title>
            <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.
Blood Flow restriction Cuff-Placebo: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Quadriceps Muscle Thickness</title>
          <description>Difference between groups in the measurement of the muscle thickness of the quadriceps muscle via ultrasound.</description>
          <population>No participants completed the placebo arm.</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <desc>No participants completed the placebo arm.</desc>
      <group_list>
        <group group_id="E1">
          <title>Blood Flow Restriction Cuff</title>
          <description>This group will receive an active cuff that partially restricts blood flow to the experimental limb.
Blood flow restriction cuff: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
        <group group_id="E2">
          <title>Blood Flow Restriction Cuff-Placebo</title>
          <description>This group will wear a placebo cuff, of which will not restrict blood flow at all.
Blood Flow restriction Cuff-Placebo: The intervention is the wearing of a cuff-like band around the affected limb, of which partially restricts blood flow to the limb.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Russel Giveans</name_or_title>
      <organization>University of Minenesota</organization>
      <phone>5042314007</phone>
      <email>russell.giveans@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

